M. Wolter

发表

Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-time reverse transcription-polymerase chain reaction.

David E. Misek, Jörg van den Boom, M. Wolter, 2003, The American journal of pathology.

The Barley Mlo Gene: A Novel Control Element of Plant Pathogen Resistance

M. Wolter, P. Schulze-Lefert, F. Salamini, 1997, Cell.

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

David T. W. Jones, V. P. Collins, M. Wolter, 2012, Cancer cell.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Christian Mawrin, Michael Weller, Christian Hartmann, 2009, Acta Neuropathologica.

Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines

M. Wolter, W. Schulz, H. Seifert, 2005, Journal of cellular physiology.

Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas

M. Wolter, G. Reifenberger, J. Felsberg, 2022, Acta Neuropathologica Communications.

Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.

Stefan Joos, Thomas Mikeska, Pearlly S Yan, 2010, Cancer research.

Unraveling the Glioma Epigenome—From Molecular Mechanisms to Novel Biomarkers and Therapeutic Targets

M. Wolter, G. Reifenberger, M. Riemenschneider, 2011, Brain pathology.

The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia

D. Steinemann, M. Wolter, M. Schrappe, 2021, Cancers.

Genomic imbalances are rare in hairy cell leukemia

M. Wolter, G. Reifenberger, H. Döhner, 1999, Genes, chromosomes & cancer.

Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.

M. Wolter, C. Sommer, G. Reifenberger, 1997, Cancer research.

Activation of a cryptic splice site of PTEN and loss of heterozygosity in benign skin lesions in Cowden disease.

M. Wolter, S. Meltzer, G. Plotz, 2001, The Journal of investigative dermatology.

Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM‐1 and DCC tumor suppressor genes on the long arm of chromosome 18

M. Wolter, G. Reifenberger, P. Lichter, 2001, International journal of cancer.

Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.

V. P. Collins, M. Wolter, G. Reifenberger, 2001, The American journal of pathology.

Supplemental Information New Brain Tumor Entities Emerge from Molecular Classi fi cation of CNS-PNETs

David T. W. Jones, Varlet, Dahiya, 2016 .

Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?

M. Wolter, G. Reifenberger, M. Weller, 2021, European journal of cancer.

The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

Alexander K. Buell, M. Wolter, G. Reifenberger, 2022, Nature Communications.

The mlo resistance alleles to powdery mildew infection in barley trigger a developmentally controlled defence mimic phenotype

M. Wolter, P. Schulze-Lefert, F. Salamini, 1993, Molecular and General Genetics MGG.

Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.

M. Wolter, G. Reifenberger, M. Sabel, 1999, Journal of neuropathology and experimental neurology.

Absence of detectable alterations in the putative tumor suppressor gene BTRC in cerebellar medulloblastomas and cutaneous basal cell carcinomas

M. Wolter, G. Reifenberger, A. Koch, 2003, Acta Neuropathologica.

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.

M. Wolter, G. Reifenberger, K. Meletis, 2010, Brain : a journal of neurology.

Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas

M. Wolter, G. Reifenberger, T. Ruzicka, 2005, The British journal of dermatology.

Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.

M. Wolter, G. Reifenberger, P. Lichter, 1998, Cancer research.

Fatal outcome in a metatypical, giant, "horrifying" basal cell carcinoma.

M. Wolter, R. Bianchini, 1987, The Journal of dermatologic surgery and oncology.

Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors

M. Wolter, G. Reifenberger, F. Berthold, 2001, International journal of cancer.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Roland Eils, Pieter Wesseling, Martin Sill, 2016, Cell.

Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas

Kai Stühler, Guido Reifenberger, M. Wolter, 2010, Brain pathology.

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors

M. Wolter, G. Reifenberger, J. Felsberg, 2005, International journal of cancer.

MicroRNA: Biogenesis, Regulation, and Role in Primary Brain Tumors

M. Wolter, G. Reifenberger, B. Malzkorn, 2009 .

Molecular signatures classify astrocytic gliomas by IDH1 mutation status

M. Wolter, G. Reifenberger, P. Lichter, 2011, International journal of cancer.

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape

M. Wolter, G. Reifenberger, M. Weller, 2014, Oncotarget.

Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas

M. Wolter, G. Reifenberger, S. Götze, 2010, International journal of cancer.

Molecular genetic alterations in glioblastomas with oligodendroglial component

Thomas Klockgether, Guido Reifenberger, Martina Beck, 2001, Acta Neuropathologica.

De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures

M. Wolter, G. Reifenberger, P. Lichter, 2010, Oncogene.

Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real‐time reverse transcription‐polymerase chain reaction

Guido Reifenberger, Jörg van den Boom, M. Wolter, 2006, International journal of cancer.

DNA hypermethylation and Aberrant Expression of the EMP3 Gene at 19q13.3 in Human Gliomas

Jörg van den Boom, M. Wolter, G. Reifenberger, 2007, Brain pathology.

The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

M. Wolter, G. Reifenberger, M. Weller, 2021, Cell Death & Disease.

Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel

Guido Reifenberger, M. Wolter, G. Reifenberger, 2017, Brain pathology.

Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.

M. Wolter, G. Reifenberger, P. Lichter, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Oligodendroglial Tumors Frequently Demonstrate Hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) Tumor Suppressor Genes

M. Wolter, G. Reifenberger, K. Ichimura, 2001, Journal of neuropathology and experimental neurology.

Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components

A. Hoischen, M. Wolter, G. Reifenberger, 2006, The Journal of pathology.

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

M. Wolter, G. Reifenberger, M. Sabel, 2010, Acta Neuropathologica.

MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.

M. Wolter, G. Reifenberger, Y. Shiio, 2014, Neuro-oncology.

Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.

M. Wolter, G. Reifenberger, H. Gabbert, 2001, American journal of clinical pathology.

Expression of Bcl-2 and amplification of c-myc are frequent in basaloid squamous cell carcinomas of the esophagus.

M. Wolter, G. Reifenberger, H. Gabbert, 1999, The American journal of pathology.

Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas

M. Wolter, G. Reifenberger, T. Werner, 2016, Brain pathology.

Frequent In activation of CDKN2A and Rare Mutation of TP53 in PCNSL

M. Wolter, G. Reifenberger, D. Louis, 1998, Brain pathology.

Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC

M. Wolter, G. Reifenberger, T. Pietsch, 2002, International journal of cancer.

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

M. Wolter, G. Reifenberger, U. Schlegel, 1999, Cancer research.

Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions.

M. Wolter, H. Geddert, H. Gabbert, 2002, American journal of clinical pathology.

P02.04MICRORNA-MEDIATED DOWN-REGULATION OF NKG2D LIGAND EXPRESSION REDUCES GLIOMA CELL IMMUNOGENICITY.

M. Wolter, G. Reifenberger, M. Weller, 2014 .

Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.

M. Wolter, G. Reifenberger, P. Lichter, 1998, Cancer research.

Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas

M. Wolter, G. Reifenberger, T. Ruzicka, 2000, Virchows Archiv.

MiR‐16‐5p is frequently down‐regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy

M. Wolter, G. Reifenberger, M. Zapatka, 2018, Neuropathology and applied neurobiology.

MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM

Fabian J Theis, M. Wolter, G. Reifenberger, 2016, Oncotarget.

Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma

M. Wolter, G. Reifenberger, D. Gutmann, 2008, International journal of cancer.

Chordoid Glioma of the Third Ventricle: Immunohistochemical and Molecular Genetic Characterization of a Novel Tumor Entity

M. Wolter, G. Reifenberger, P. Lichter, 1999, Brain pathology.

Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.

M. Wolter, G. Reifenberger, U. Schlegel, 2010, Neuro-oncology.

Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro

M. Wolter, G. Reifenberger, P. Lichter, 2012, Oncogene.

ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma

M. Wolter, G. Reifenberger, A. Tannapfel, 2009, BMC Cancer.

Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.

M. Wolter, G. Reifenberger, D. Nam, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components

M. Wolter, G. Reifenberger, R. Büschges, 2002, Genes, chromosomes & cancer.

Hypermethylation and Transcriptional Downregulation of the TIMP3 Gene is Associated with Allelic Loss on 22q12.3 and Malignancy in Meningiomas

M. Wolter, G. Reifenberger, M. Riemenschneider, 2010, Brain pathology.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Volker Hovestadt, Stefan M. Pfister, Brent A. Orr, 2016, Cell.

DNA content and cell proliferation in giant congenital melanocytic naevi (GCMN)

M. Wolter, N. Brousse, S. Fraitag, 1998, Journal of cutaneous pathology.

Absence of mutations in the putative tumor suppressor gene KLF6 in glioblastomas and meningiomas

M. Wolter, G. Reifenberger, B. Blaschke, 2004, International journal of cancer.

Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification.

M. Wolter, G. Reifenberger, U. Schlegel, 1999, Cancer research.

Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas

M. Wolter, G. Reifenberger, S. Götze, 2010, International journal of cancer.

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

David T. W. Jones, R. Eils, M. Wolter, 2016, Cell.